Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for tamoxifen ocular toxicity: a prospective study

R Therssen1, E Jansen, A Leys

  • 1Department of Ophthalmology, St-Elisabeth Hospital, Turnhout, Belgium.

European Journal of Ophthalmology
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility in a homeopathy for seasonal allergic rhinitis RCT: importance of therapeutic relationship and organizational capacity.

Frontiers in allergy·2026
Same author

Neural correlates of inhibitory control during a simple food go/no-go task in adolescents varying in familial obesity risk.

NeuroImage·2025
Same author

Hydrotherapy and acupressure for restless legs syndrome: results of a qualitative part of a randomized controlled exploratory study.

Frontiers in medicine·2025
Same author

Causes of mortality and morbidity in the endangered southern brown bandicoot (Isoodon obesulus obesulus).

Australian veterinary journal·2025
Same author

Measurement is the foundation of research and theory on children's eating behaviours: Current issues and directions for progress.

Appetite·2023
Same author

Development and validation of the Symptomatic Transdiagnostic Test (S2T).

L'Encephale·2023
Same journal

Distinct interactions between macular neovascularization and geographic atrophy: Growth dynamics and fellow-eye risk.

European journal of ophthalmology·2026
Same journal

Association of spousal smoking exposure with epiretinal membrane in lifelong non-smoking women: A dyadic analysis of KNHANES 2019-2021.

European journal of ophthalmology·2026
Same journal

Long-term smoking and early-onset diabetic retinopathy in young-onset type 2 diabetes.

European journal of ophthalmology·2026
Same journal

Optimizing mitomycin C in photorefractive keratectomy: A paired-eye comparison of 15- versus 30-second applications.

European journal of ophthalmology·2026
Same journal

Honeycomb Keratopathy due to Rho-kinase inhibitor therapy.

European journal of ophthalmology·2026
Same journal

Mendelian randomisation in ophthalmology: An overview and practical guide for clinicians.

European journal of ophthalmology·2026
See all related articles

Tamoxifen can cause ocular complications like retinopathy and optic neuritis. Routine screening for all patients is unnecessary, but regular eye exams are advised for those on adjuvant therapy.

Area of Science:

  • Ophthalmology
  • Oncology
  • Pharmacology

Background:

  • Tamoxifen is a widely used medication for breast cancer treatment.
  • Ocular side effects, including retinopathy, keratopathy, and optic neuritis, have been associated with tamoxifen use.
  • The incidence and necessity of screening for these complications require further investigation.

Observation:

  • This study evaluated 61 patients using tamoxifen for at least one year.
  • The researchers aimed to determine the frequency of ocular complications in this patient cohort.
  • Patients were assessed for visual disturbances and specific ocular conditions.

Findings:

  • Two patients developed retinopathy after high cumulative tamoxifen doses.
  • One patient presented with corneal deposits.

Related Experiment Videos

  • A fourth patient was diagnosed with optic neuritis.

    • Implications:

    • Systematic screening for all asymptomatic patients on tamoxifen for metastatic breast cancer may not be necessary.
    • Regular ophthalmological assessments (every two years or sooner if symptomatic) are recommended for patients on adjuvant tamoxifen therapy.
    • Early detection of ocular complications allows for potential adjustments in oncological treatment to mitigate risks.